Premium
The Bone Morphogenetic Proteins Antagonist Noggin Inhibits Membranous Ossification
Author(s) -
Aspenberg Per,
Jeppsson Charlotte,
Economides Aris N.
Publication year - 2001
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1359/jbmr.2001.16.3.497
Subject(s) - noggin , bone morphogenetic protein , microbiology and biotechnology , bone morphogenetic protein 2 , bone morphogenetic protein 7 , ossification , chemistry , bone morphogenetic protein 5 , endocrinology , medicine , morphogenesis , biology , anatomy , biochemistry , in vitro , gene
Bone morphogenetic proteins (BMPs) are expressed and secreted during fracture repair. Although they are likely to be required for this process, little is known about their physiological role in bone regeneration. Noggin is a protein that specifically binds and inactivates several BMPs. It plays fundamental roles during early embryonal development and limb morphogenesis by this BMP‐inactivating activity. This study shows that Noggin can modify bone formation in vivo in the adult animal and, thus, indirectly, that BMP signaling is indispensable in this process. A noggin mutein (hNgΔB2‐Fc) engineered so as to display increased bioavailability was used. Bilateral titanium bone chambers were inserted in 70 rats, and side comparisons for bone formation in the chambers were done. The hNgΔB2‐Fc had no effect on total amount of tissue formed in the chamber but decreased the amount of bone compared with both buffer controls and a control made up of an Fc‐tagged IL‐6Rα protein, which had no effects of its own. Also, wild‐type noggin inhibited bone formation. Thus, endogenous BMP signaling is necessary for normal bone regeneration.